4,6-disubstitued pyrimidines useful as kinase inhibitors
US7982036B2 · kind B2 · utility
11Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2008 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Oct 17, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula Iwherein Ring A, Ring B, m, Rx, Ry, W and R1 are as defined herein, pharmaceutically acceptable salts and compositions thereof, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.